Navigation Links
NJHA: Hospital Finances Show Troubling Trends
Date:11/25/2008

Report Says 2007 Total Margins Shrunk; Nearly Half Lost Money

PRINCETON, N.J., Nov. 25 /PRNewswire-USNewswire/ -- Nearly half of the state's hospitals - 47 percent - posted overall losses at the end of 2007, according to new audited financial data contained in the 2008 edition of the New Jersey Hospital Association's Financial Status of New Jersey Hospitals report.

The data shows that New Jersey's hospital industry was on shaky financial ground long before the recent economic meltdown.

New Jersey hospitals reported a dramatic decrease in hospital total margins in 2007, which include income from restricted and non-operating funds such as grants, endowments and investments. The statewide average total margin dropped from 3.1 percent in 2006 to 0.9 percent for 2007 - the lowest it has been since 2002. The 2007 data did reflect a modest increase in year-end operating margins, from 0.6 percent in 2006 to 1.3 percent in 2007. However, the 2007 figure constitutes the 11th consecutive year that New Jersey hospital operating margins have been less than 2 percent.

Compiled from audited financial data submitted by acute care and specialty hospitals and health systems statewide, the report shows total 2007 hospital revenues of $18.263 billion and total expenses of $18.026 billion. The resulting $237 million gain represents a 1.3 percent operating margin, up from 0.6 percent posted at year-end 2006. However, losses from non-operating funds of $70.5 million lowered the total income to $167 million, for an overall margin of only 0.9 percent.

In the same year, three New Jersey acute care hospitals closed and five filed for bankruptcy. "This data underscores the longstanding challenges New Jersey hospitals face in remaining financially sound in the face of insufficient reimbursement from Medicare, Medicaid and the state charity care program," said NJHA President and CEO Betsy
'/>"/>

SOURCE New Jersey Hospital Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NJHA: Hospitals Achieve Gains in Healthcare Quality, But Commitment to Improve Continues
2. NJHA: Public Deserves Full Disclosure of Horizon Conversion Plan
3. NJHA: No Hospital Safe from States $143 Million Cut
4. NJHA: State Faces Access-to-Care Crisis
5. NJHA: State Report Provides Thorough Examination of Hospital Fiscal Woes
6. Bon Secours St. Marys Is First Hospital in U.S. to Perform New Gastric Banding Procedure
7. Pennsylvania Hospital Pays $1.9 Million to Settle Medicare Fraud Case Brought by Whistleblower
8. Transfusions increase clot risk in hospitalized cancer patients
9. CVS/pharmacy Raising Funds for the St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign to Support Expanded Rehabilitation Services Center
10. Marlo Thomas and St. Jude Childrens Research Hospital(R) Kick Off The 5th Anniversary of the Thanks and Giving(R) Campaign Asking America to Support St. Jude While Shopping this Holiday Season
11. Holiday Health Tips From Packard Childrens Hospital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , Dr. Redlener Applauds Historic Effort b...et Programs Are Lost in Final Health Care Reform ... The New England Journal of Medicine today pub...th care reform, co-authored by Irwin Redlener, M.D... National Center for Disaster Preparedness and Pro...
(Date:12/4/2009)...with knowledge of risks, many hesitate to take bre... Dec. 4 (HealthDay News) -- Worries about side eff...ican women at high risk for breast cancer are will...ase, a new study finds. , In an effort to infor... researchers at the University of Michigan Compreh...
(Date:12/4/2009)... , BOULDER, Colo., Dec. 4 ..., ON LOVE ,, Kathryn Budig, a prominent yoga te...e to healing--with a viewing of Twilight,s New Moo...nal.com: ,, http://www.elephantjournal.com/200...ournal.com: TASHI KING AND BREAST CANCER ,, el...
(Date:12/4/2009)... , JEFFERSON CITY, Mo., Dec. 4 /PRNewswire/ ...ctor Paul Crosetti, State Fire Marshal Randy Cole,...en,s fire safety program sponsored by Farmers call... safety day at the Missouri Capitol December 9. .../20080605/LATH062 ) ,, "The call for fire safet...
(Date:12/4/2009)...le who have had an ischemic stroke are at higher l... of medication can reduce that risk. One of the si...s, otherwise known as blood thinners, of which the...tudy to determine whether the use of antithromboti...r a seven-year period found that in each of the ye...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Missouri Safety Day at the Capitol 2Health News:Are stroke survivors taking their medicine? 2
..., Dec. 3 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP...igational new,drug (IND) application to the U.S. F...und is an internally developed, orally-bioavailabl...r,patients in early 2008., "This IND submission i...
... N.Y., Dec. 3 Big A Drug Stores, Inc. has,selecte...al estate,solutions, to exclusively manage the dis...California. Big A Drug Stores, Inc. is a chain of ...gs,","Drug Fair," and "Drug Barn" (2 stores)., "W...
...APOLIS Although more and more drug advertisements...oximately $21 billion dollars that pharmaceutical ...is targeted to physicians, doctors in training (re...c. published in the December issue of the journal ...
...and PITTSBURGH, Dec. 2 Forest,Laboratories, Inc. ...ed that,Mylan has received an approvable letter fr...response to its New Drug Application (NDA) for,neb...icated that a recent inspection of,a backup manufa...
... communication with doctors and respect for role o...Y, Dec. 2 (HealthDay News) -- The death of a child...dparents, siblings, friends, even the child,s doct...ymptoms and stress of life-threatening illness -- ...
...ESTER, Ill. Hospital staff nurses who work extend...at work, or obtain less sleep are more likely to e... study published in the December 1 issue of the jo...ed from 895 full-time hospital staff nurses, who c...
Other Medicine News:Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 3Health News:Big A Drug Stores, Inc. Retains DJM Realty to Dispose of All Stores Operating Under the Names of Drug Emporium, Big A, Camelot, Drug Fair and Drug Barn 2Health News:Do medical schools affect the way future doctors interact with drug companies? 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 3Health News:Breaking Down Barriers to End-of-Life Care for Children 2Health News:Breaking Down Barriers to End-of-Life Care for Children 3Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 2Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 3Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 4
(Date:12/4/2009)..., , BETHESDA, Md., Dec. 4 Dr...lts for prostate-specific antigen (PSA) recurrence...nts of biochemical recurrence rate in a Phase III ... for injection) or monthly leuprolide in prostate .... Prostate cancer patients who received FIRMAGON ...
(Date:12/3/2009)..., , NEW YORK, Dec. 3 Guid...rm, today announced the launch of their Sleep Apne...t monitors and projects trends and market share in...p Apnea Tracker captures actual patient usage for ...nited States from 15 different equipment providers...
(Date:12/3/2009)..., , SUNNYVALE, Calif., Dec. 3 /PRNewswire-..., a biopharmaceutical company focused on developin...ugs for the treatment of immune mediated diseases ...bcast and conference call on, Tuesday, December 8,...e and 8:00am Pacific Time) to discuss clinical dat...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 1Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 2Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 3ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 1ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 1CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 3
...nc., a privately held biopharmaceutical company th...mmercialization of prescription ophthalmic pharmac... safety and efficacy results from the first human ...luocinolone acetonide (FA) intravitreal insert) wi...ion for Research in Vision and Ophthalmology (ARVO...
...President and Chief Executive Officer of Smithfiel...pdate to all employees on the progress of the test... in Veracruz: , , To Our Employees: , , The medi...outbreak on a minute-to-minute basis, and while we...ut the day-to-day status of the testing being cond...
Other Medicine Technology:Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting 2Smithfield Sends Update to Employees on Testing Process at Veracruz Joint Venture 2
HOME MULTI-DRUG TEST
SEDIPLAST ESR SYSTEM (with diluent)
SEDIPLAST ESR SYSTEM (without diluent)
Hemaprompt FG Gastric and Fecal Occult Blood Test
Medicine Products: